WEKO3
アイテム
{"_buckets": {"deposit": "7cea58ae-1b18-422e-9850-ca03fd4c1d84"}, "_deposit": {"created_by": 3, "id": "20204", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "20204"}, "status": "published"}, "_oai": {"id": "oai:twinkle.repo.nii.ac.jp:00020204", "sets": ["2023"]}, "author_link": ["294834", "294836", "294835", "294837"], "item_10001_alternative_title_1": {"attribute_name": "別タイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Cerebrovascular Disease : Recent Progress in Research and Clinical Practice (5) : Hemostatic Abnormalities in Cerebrovascular Disease"}]}, "item_10001_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2007-06", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "6", "bibliographicPageEnd": "280", "bibliographicPageStart": "275", "bibliographicVolumeNumber": "77", "bibliographic_titles": [{"bibliographic_title": "東京女子医科大学雑誌"}]}]}, "item_10001_creator_2": {"attribute_name": "著者名", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "山崎, 昌子"}], "nameIdentifiers": [{"nameIdentifier": "294834", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "内山, 真一郎"}], "nameIdentifiers": [{"nameIdentifier": "294835", "nameIdentifierScheme": "WEKO"}]}]}, "item_10001_date_25": {"attribute_name": "受付日付", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2010-08-10", "subitem_date_issued_type": "Created"}]}, "item_10001_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Various hemostatic tests are used to understand the mechanism of thrombus formation in cerebral infarction, and are useful for diagnosis and treatment of the infarction. Hemostatic markers show different patterns of abnormalities among the clinical categories of cerebral infarction, that is atherothrombotic, lacunar, and cardioembolic. The different patterns of abnormalities are suggested to reflect both the underlying pathophysiological mechanisms and the hemostatic activation induced by cerebral infarction itself. On the other hand, it is known that various hemostatic abnormalities can cause cerebral infarction. In particular, in patients who suffered cerebral infarction without atherosclerotic changes in their vessels, it is necessary to perform various hemostatic tests to investigate the etiology of the cerebral infarction. Hemostatic tests are also useful to monitor the intensity of antithrombotic therapy during the treatment of cerebral infarction. The international normalized ratio (INR) of prothrombin time is used as an index for anticoagulation with warfarin. The recommended INR level differs according to the underlying heart disease which caused the cerebral infarction. Contrary to anticoagulation, there is no established marker for antiplatelet therapy, but it is necessary to develop a method to monitor the intensity of recent potent antiplatelet therapy.", "subitem_description_type": "Abstract"}]}, "item_10001_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "294836", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "YAMAZAKI, Masako"}]}, {"nameIdentifiers": [{"nameIdentifier": "294837", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "UCHIYAMA, Shinichiro"}]}]}, "item_10001_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "東京女子医科大学学会"}]}, "item_10001_source_id_11": {"attribute_name": "NCID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00161368", "subitem_source_identifier_type": "NCID"}]}, "item_10001_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0040-9022", "subitem_source_identifier_type": "ISSN"}]}, "item_10001_subject_47": {"attribute_name": "著者キーワード", "attribute_value_mlt": [{"subitem_subject": "cerebral infarction", "subitem_subject_scheme": "Other"}, {"subitem_subject": "thrombus formation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "hemostatic markers", "subitem_subject_scheme": "Other"}, {"subitem_subject": "hemostatic abnormalities", "subitem_subject_scheme": "Other"}, {"subitem_subject": "monitoring", "subitem_subject_scheme": "Other"}]}, "item_10001_text_35": {"attribute_name": "著者所属", "attribute_value_mlt": [{"subitem_text_value": "東京女子医科大学医学部神経内科学"}, {"subitem_text_value": "東京女子医科大学医学部神経内科学"}]}, "item_10001_version_type_20": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-08-22"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "KJ00006024382.pdf", "filesize": [{"value": "644.3 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 644300.0, "url": {"label": "KJ00006024382.pdf", "url": "https://twinkle.repo.nii.ac.jp/record/20204/files/KJ00006024382.pdf"}, "version_id": "d9f821bc-3fbc-4ed9-b1df-144cd05af501"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "脳血管障害-研究と診療の進歩(5) : 脳血管障害の凝血学的検査", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "脳血管障害-研究と診療の進歩(5) : 脳血管障害の凝血学的検査"}]}, "item_type_id": "10001", "owner": "3", "path": ["2023"], "permalink_uri": "http://hdl.handle.net/10470/27503", "pubdate": {"attribute_name": "公開日", "attribute_value": "2010-08-10"}, "publish_date": "2010-08-10", "publish_status": "0", "recid": "20204", "relation": {}, "relation_version_is_last": true, "title": ["脳血管障害-研究と診療の進歩(5) : 脳血管障害の凝血学的検査"], "weko_shared_id": -1}
脳血管障害-研究と診療の進歩(5) : 脳血管障害の凝血学的検査
http://hdl.handle.net/10470/27503
http://hdl.handle.net/10470/2750385b3da36-5705-482a-8626-1b07b8fdf737
名前 / ファイル | ライセンス | アクション |
---|---|---|
KJ00006024382.pdf (644.3 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-08-10 | |||||
タイトル | ||||||
タイトル | 脳血管障害-研究と診療の進歩(5) : 脳血管障害の凝血学的検査 | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
別タイトル | ||||||
その他のタイトル | Cerebrovascular Disease : Recent Progress in Research and Clinical Practice (5) : Hemostatic Abnormalities in Cerebrovascular Disease | |||||
著者名 |
山崎, 昌子
× 山崎, 昌子× 内山, 真一郎 |
|||||
著者別名 | ||||||
姓名 | YAMAZAKI, Masako | |||||
著者別名 | ||||||
姓名 | UCHIYAMA, Shinichiro | |||||
出版者 | ||||||
出版者 | 東京女子医科大学学会 | |||||
受付日付 | ||||||
日付 | 2010-08-10 | |||||
日付タイプ | Created | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0040-9022 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00161368 | |||||
書誌情報 |
東京女子医科大学雑誌 巻 77, 号 6, p. 275-280, 発行日 2007-06 |
|||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Various hemostatic tests are used to understand the mechanism of thrombus formation in cerebral infarction, and are useful for diagnosis and treatment of the infarction. Hemostatic markers show different patterns of abnormalities among the clinical categories of cerebral infarction, that is atherothrombotic, lacunar, and cardioembolic. The different patterns of abnormalities are suggested to reflect both the underlying pathophysiological mechanisms and the hemostatic activation induced by cerebral infarction itself. On the other hand, it is known that various hemostatic abnormalities can cause cerebral infarction. In particular, in patients who suffered cerebral infarction without atherosclerotic changes in their vessels, it is necessary to perform various hemostatic tests to investigate the etiology of the cerebral infarction. Hemostatic tests are also useful to monitor the intensity of antithrombotic therapy during the treatment of cerebral infarction. The international normalized ratio (INR) of prothrombin time is used as an index for anticoagulation with warfarin. The recommended INR level differs according to the underlying heart disease which caused the cerebral infarction. Contrary to anticoagulation, there is no established marker for antiplatelet therapy, but it is necessary to develop a method to monitor the intensity of recent potent antiplatelet therapy. | |||||
著者所属 | ||||||
東京女子医科大学医学部神経内科学 | ||||||
著者所属 | ||||||
東京女子医科大学医学部神経内科学 | ||||||
著者キーワード | ||||||
主題Scheme | Other | |||||
主題 | cerebral infarction | |||||
著者キーワード | ||||||
主題Scheme | Other | |||||
主題 | thrombus formation | |||||
著者キーワード | ||||||
主題Scheme | Other | |||||
主題 | hemostatic markers | |||||
著者キーワード | ||||||
主題Scheme | Other | |||||
主題 | hemostatic abnormalities | |||||
著者キーワード | ||||||
主題Scheme | Other | |||||
主題 | monitoring |